Escalon Medical Corp.
Income Statement
| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6M | $3.6M | $2.7M | $2.6M | $3.5M | $3.2M | $2.8M | $3.5M |
| Cost of Revenue | $1.7M | $2.0M | $1.6M | $1.4M | $1.9M | $1.6M | $1.6M | $2.0M |
| Gross Profit | $946.7K | $1.6M | $1.1M | $1.1M | $1.6M | $1.6M | $1.2M | $1.5M |
| Gross Margin | 36.3% | 43.3% | 41.9% | 43.7% | 46.1% | 48.9% | 43.6% | 42.4% |
| Operating Expenses | ||||||||
| Research & Development | $29.9K | $131.2K | $216.1K | $291.6K | $164.8K | $155.9K | $140.9K | $173.0K |
| SG&A Expense | $1.3M | $1.3M | $1.1M | $1.2M | $1.2M | $1.2M | $1.1M | $1.2M |
| Operating Income | $-419.3K | $98.7K | $-202.8K | $-371.8K | $276.0K | $255.9K | $-27.0K | $138.3K |
| Operating Margin | -16.1% | 2.7% | -7.6% | -14.5% | 7.9% | 7.9% | -1.0% | 4.0% |
| Interest Expense | — | — | — | — | $4.6K | $4.9K | $5.3K | $3.9K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $2.4M | $97.7K | $-239.9K | $-379.8K | $271.5K | $246.0K | $-32.2K | $134.4K |
| Net Margin | 91.0% | 2.7% | -9.0% | -14.8% | 7.8% | 7.6% | -1.2% | 3.9% |
| EPS (Basic) | $0.16 | $0.01 | $-0.03 | $-0.03 | $0.02 | $0.02 | $-0.01 | $0.01 |
| EPS (Diluted) | $0.16 | $0.01 | $-0.03 | $-0.03 | $0.02 | $0.02 | $-0.01 | $0.01 |
| Shares Outstanding (Basic) | 7.4M | 7.4M | 7.4M | 7.4M | 7.4M | 7.4M | 7.4M | 7.4M |
| Shares Outstanding (Diluted) | 14.5M | 14.4M | 7.4M | 14.3M | 14.2M | 14.1M | 7.4M | 7.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |